Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) analogue that plays a central role in glucose homeostasis. In research, it is extensively studied for its ability to enhance insulin release, reduce appetite, and support weight loss.
Key applications in scientific studies include:
-
Modulating blood glucose levels in Type 2 diabetes models.
-
Promoting satiety and reducing caloric intake, relevant in obesity and metabolic syndrome research.
-
Enhancing insulin sensitivity, especially in insulin-resistant subjects.
-
Cardiovascular and hepatic benefits, as shown in lipid profile and liver fat reduction studies.
Semaglutide’s extended half-life allows for once-weekly dosing in research, increasing consistency in longitudinal metabolic studies.
Reconstitution Instructions:
Reconstitute with BAC water. Refrigerate after reconstitution and use under sterile research conditions. Use our Peptide Calculator
For research purposes only. Not for human consumption.
Reviews
There are no reviews yet.